D-glycerate dehydrogenase deficiency
| D-glycerate dehydrogenase deficiency | |
|---|---|
| Other names | 3-phosphoglycerate dehydrogenase deficiency, PHGDH deficiency, PHGDHD |
| Condition is acquired via an autosomal recessive pattern | |
| Specialty | Metabolism |
| Symptoms | Congenital microcephaly, psychomotor retardation and seizures in infants, moderate developmental delay and behavioral disorders juveniles. |
| Usual onset | Adolescent, Infancy, Childhood |
| Causes | Genetic |
| Prevention | N/A |
| Treatment | Diet |
| Medication | Serine |
| Prognosis | Shortened life expectancy |
| Frequency | <1 / 1 000 000 |
D-glycerate dehydrogenase deficiency (or 3-phosphoglycerate dehydrogenase deficiency, PHGDH deficiency, PHGDHD) is a rare autosomal metabolic disease where the young patient is unable to produce an enzyme necessary to convert 3-phosphoglycerate into 3-phosphohydroxypyruvate, which is the only way for humans to synthesize serine. This disorder is called Neu–Laxova syndrome in neonates.